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Vitamin D functions are not limited to skeletal health beneﬁts and may extend to preservation of insulin secretion and insulin
sensitivity. This review summarizes the literature related to potential vitamin D inﬂuences on glucose homeostasis and insulin
sensitivity. Cross-sectional data provide some evidence that circulating 25-hydroxyvitamin D (25(OH)D) is inversely associated
with insulin resistance, although direct measurements of insulin sensitivity are required for conﬁrmation. Reported associations
with insulin secretion, however, are contradictory. Available prospective studies support a protective inﬂuence of high 25(OH)D
concentrations on type 2 diabetes mellitus risk. There is a general lack of consistency in vitamin D intervention outcomes on
insulin secretion and sensitivity, likely due to diﬀerences in subject populations, length of interventions, and forms of vitamin
D supplementation. Vitamin D receptor gene polymorphisms and vitamin D interactions with the insulin like growth factor
system may further inﬂuence glucose homeostasis. The ambiguity of optimal vitamin D dosing regimens and optimal therapeutic
concentrations of serum 25(OH)D limit available intervention studies. Future studies, including cross-sectional and prospective,
should be performed in populations at high risk for both vitamin D deﬁciency and type 2 diabetes mellitus. Well-designed,
placebo-controlled, randomized intervention studies are required to establish a true protective inﬂuence of vitamin D on glucose
homeostasis.
1.Introduction
Over the last decade, numerous nonskeletal disease asso-
ciations have been reported with vitamin D deﬁciency,
including type 2 diabetes mellitus (T2DM). Circulating 25-
hydroxyvitamin D (25(OH)D) concentrations are consid-
ered an indicator of vitamin D status [1, 2]. Compared to
healthy controls, subjects with T2DM have been observed to
have signiﬁcantly lower circulating 25(OH)D concentrations
[3–5]. Perhaps not coincidently, both vitamin D deﬁciency
and T2DM share the same risk factors, including African-
American, Asian, or Hispanic ethnicity, increased adiposity,
age,andphysicalinactivity(whichmaytranslatetodecreased
time spent outdoors or reduced sun exposure) [6, 7].
Seasonal variations in glucose and insulin concentrations
have been reported [8], which may correlate with seasonal
variations in 25(OH)D concentrations [9]. Although not
within the scope of this review, vitamin D has likewise been
implicated in the development of type 1 diabetes mellitus
due to its modulation of the immune system [10]. T2DM
is considered a state of insulin resistance (beta cell com-
pensation) and insulinopenia (beta cell decompensation)
and is characterized by progressive deterioration in beta
c e l lf u n c t i o na n de v e n t u a ll o s so fb e t ac e l lm a s s[ 11]. The
mechanism by which vitamin D deﬁciency and T2DM are
related is not well known.
We performed a computerized PubMed search of English
language original and review articles through March 2009
using the terms “vitamin D”, “insulin”, “insulin sensitivity”,
“insulin resistance”, “insulin secretion”, and other related
terms. This review provides a comprehensive summary
of the literature available relating vitamin D to insulin
secretionandsensitivity,includingthepotentialmechanisms
mediating the vitamin D-glucose homeostasis relationship;2 International Journal of Endocrinology
supportive or contradictory cross-sectional, prospective,
and intervention studies; as well as potential interactions
of vitamin D with the insulin like growth factor (IGF)




Pittas et al. [9] have summarized the biological evidence
implicating a potential inﬂuence of vitamin D on glucose
homeostasis.Theinferencesforthemanifoldrolesofvitamin
D include the presence of speciﬁc vitamin D receptors
(VDRs) on pancreatic β-cells [12], the expression of 1-α-
hydroxylase enzyme in pancreatic β-cells which catalyzes
the conversion of 25(OH)D to 1, 25-dihydroxyvitamin D
(1,25(OH)2D) [13], the presence of a vitamin D response
element in the human insulin gene promoter [14], and
the presence of VDR in skeletal muscle [15]. In addition,
1,25(OH)2D directly activates transcription of the human




Animal and in vitro studies provide compelling evidence
that vitamin D may play a functional role in the preservation
of glucose tolerance through its eﬀects on insulin secretion
and insulin sensitivity. Vitamin D deﬁcient rabbits and mice
present with impaired insulin secretion, and supplementa-
tion with vitamin D corrects the defect [19–22]. Mice with
mutations in the VDR have impaired insulin secretion and
lower glucose tolerance than those with functional receptors
[23]. In vitro, 1,25(OH)2D induces the biosynthesis of
insulin in rat pancreatic islet cells [24], and in another
study, inhibited free fatty acid-induced insulin resistance
(i.e., improved glucose uptake) in cultured myocytes in a
dose-dependent manner. The insulin sensitizing eﬀects were
mediated by a reduction in JNK activation [25].
Although the skeletal eﬀects of vitamin D occur via an
endocrine mechanism, there may be an autocrine/paracrine
role of vitamin D in insulin target tissues. Pancreatic β-cells
express the vitamin D receptor (VDR) as well as the pivotal
enzyme 1α-hydroxylase [12, 13]. VDR is also expressed by
both human skeletal muscle and adipose tissue [26, 27],
which are the main determinants of peripheral insulin
sensitivity. These tissues were shown to express the 1α-
h y d r o x y l a s eg e n ei nm a l eW i s t a rr a t s[ 28]. Notably, skeletal
muscle expression of VDR declines with age [29], as does
insulin sensitivity.
Vitamin D deﬁciency may inﬂuence its eﬀects on insulin
secretion and sensitivity via its eﬀects on intracellular
calcium [9]. Elevated intracellular calcium impairs postre-
ceptor binding insulin action, such as the dephosphorylation
of glycogen synthase and of insulin regulatable glucose
transporter (GLUT-4) [30, 31]. Vitamin D deﬁciency results
in elevated parathyroid hormone (PTH) [2], which in turn is
known to elevate intracellular calcium [31]. Sustained eleva-
tions of intracellular calcium may inhibit insulin-target cells
from sensing the brisk intracellular calcium ﬂuxes necessary
for insulin action, such as glucose transport [32]. Pancreatic
β-cellsalso depend on an acute intracellular calcium increase
for insulin secretion [33], which may also be attenuated with
elevatedcytosoliccalcium[34].Anotherpossiblemechanism
is that elevated intracellular calcium enhances calmodulin
binding to insulin receptor substrate-1 (IRS-1), which
interferes with insulin-stimulated tyrosine phosphorylation
and PI3-kinase activation [35–37]. Indeed, PTH has been
shown to be inversely associated with insulin sensitivity
[38, 39]. On the other hand, Kamycheva et al. [40] did not
ﬁnd signiﬁcant diﬀerences in insulin or glucose metabolism
in subjects with secondary hyperparathyroidism versus
controls. Nevertheless, dichotomization based on serum
25(OH)D concentrations appeared to determine diﬀerences
in insulin sensitivity. It is arguable that the insulin resistance
seen in vitamin D deﬁcient subjects is not fully explained by
these aforementioned molecular mechanisms alone.
3.Cross-SectionalData
Reports on associations between insulin secretion and
25(OH)D have been inconsistent (Table 1(a)). The diﬀer-
ences in this relationship are likely due to diﬀerences in
subject populations and disparate methods to determine
insulin secretion. Boucher et al. [41] reported a signiﬁcant
positive association between 25(OH)D and oral glucose
tolerance test- (OGTT-) induced insulin secretion in East
London Asians at risk for T2DM, although Orwoll et al.
[42] reported no association between 25(OH)D and meal-
induced insulin secretion in men with T2DM (mean glyco-
sylated hemoglobin, HbA1c: 11.5 ± 3.5%). It is possible that
vitamin D is unable to augment insulin secretion in uncon-
trolled T2DM subjects who have already exhausted their
insulin secretory capacity. Analyses of the National Health
and Nutrition Examination Survey 1989–1994 (NHANES
III) disclosed that serum 25(OH)D was inversely associated
with diabetes risk and measures of insulin resistance despite
there is no association between 25(OH)D concentrations
and the homeostasis model assessment of β-cell function
(HOMA-β, an index of β-cell function derived from fasting
insulin and glucose concentrations) [5]. Signiﬁcant inverse
associations have been reported between 25(OH)D and
OGTT-induced insulin secretion in elderly Dutch men [4],
hyperglycemic clamp-induced insulin response in glucose
tolerant subjects of various ethnic backgrounds [43], and
hyperglycemic clamp-induced insulin response in Norwe-
gian subjects with secondary hyperparathyroidism [40].
Although an inverse association between 25(OH)D and
insulin secretion may seem contradictory to the hypothesis
that vitamin D is necessary for β-cell synthesis of insulin,
subjects with insulin resistance, but not T2DM, often expe-
rience compensatory hyperinsulinemia [44]. Thus, inverse
statistical associations of vitamin D with insulin secretion
may be mediated through vitamin D inﬂuences on insulin
sensitivity, as shown by Chiu et al. [43].
In general, cross-sectional studies, including large-scale
population studies such as NHANES III [5, 45], have shownInternational Journal of Endocrinology 3
a signiﬁcant positive relationship between serum 25(OH)D
and measures of insulin sensitivity [4, 5, 40, 43, 45–48]
(Table 1(b)). This relationship has been corroborated in
a variety of populations including pregnant and pediatric
populations [49, 50].
A limitation to the available cross-sectional data is that,
with the exception of few studies [40, 43, 51, 52], many
studies investigating relationships between 25(OH)D and
insulin secretion and sensitivity have used indirect proxy
measures, such as fasting insulin, fasting or postchallenge
glucose, the homeostasis model assessment of insulin
resistance (HOMA-IR), HOMA-β, the quantitative insulin-
sensitivity index (QUICKI), postchallenge insulin, or HbA1c
[4, 5, 42, 46–49, 53], instead of the paragon investigation
and the hyperglycemic clamp. The accuracy of proxy
measures of insulin sensitivity may vary depending on
obesity status or ethnicity [54]. In addition, the majority
of studies investigating the association between 25(OH)D
and insulin metabolism have used BMI, rather than a
direct measure of adiposity as a covariate in analyses
[4, 5, 40, 41, 43, 51, 53, 55]. The accuracy of BMI in
reﬂecting adiposity has been questioned, and when studies
have used both dual energy X-ray absorptiometry-(DXA-
) derived total body fat and BMI in models to predict
25(OH)D, only total body fat emerged as an independent
predictor [56–58] .A l s o ,m a n ys t u d i e sh a v en o ta c c o u n t e d
for confounders that may be mediating associations between
25(OH)D and insulin sensitivity, such as physical activity
and calcium intake [9], each of which has been shown to
be signiﬁcantly associated with insulin sensitivity and may,
thus, corrupt data analysis. Furthermore, inherent to the
nature of the cross-sectional study design, studies using this
design are limited in their ability to infer causation.
Insulin sensitivity may not be inﬂuenced by circulating
25(OH)D in some populations. Manco et al. [59]i n v e s t i -
gated the associations of 25(OH)D with insulin sensitivity
(determined with a euglycemic-hyperinsulinemic clamp) in
morbidly obese Caucasian women. Serum 25(OH)D was
not associated with insulin sensitivity in these subjects
either before bariatric surgery or 5 and 10 years post-
surgery.Suggestingthattheoftenfoundlowserum25(OH)D
concentrations before and after bariatric surgery do not
negatively aﬀect insulin sensitivity. Other anthropometric
factors, such as the extreme adiposity prior to surgery and
the improved metabolic and lipid proﬁle postsurgery, likely
had a greater impact than 25(OH)D on insulin sensitivity.
NHANES III data did not show a signiﬁcant relationship
between 25(OH)D and HOMA-IR in African Americans
despite there are signiﬁcant results in Caucasian and Mex-
ican Americans [5], and Alemzadeh et al. [50]r e p o r t e d
a signiﬁcant relationship between serum 25(OH)D and
HbA1cin Caucasianbutnotin AfricanAmericans.Similarly,
in a meta-analysis of the association between 25(OH)D
and T2DM prevalence, Pittas et al. [9] found an OR of
0.36 (95% CI: 0.16–0.08) for the highest concentrations of
25(OH)D compared to the lowest, although this signiﬁcant
OR only appeared after African Americans were excluded
fromanalyses.Itisunclearwhetherdisparateethnicities have
diﬀerentoptimal serumconcentrationsof25(OH)D,andthe
relationships of serum 25(OH)D with glucose homeostasis
should be examined in African Americans using direct
measures of insulin sensitivity and secretion to conﬁrm a
nugatory eﬀect of 25(OH)D.
4.ProspectiveStudies
Few studies have examined the predictive value of 25(OH)D
on future risk of T2DM [60–62]. Forouhi et al. [61]f o u n d
baseline 25(OH)D to be inversely associated with fasting
glucose,fastinginsulin,andHOMA-IRatthe10-yearfollow-
up of the Medical Research Council Ely Prospective Study
(European-origin adults), independent of baseline outcome
values. Similarly, in the Mini-Finland Health Study, the
relative risk for T2DM was 0.60 in subjects with the
highest 25(OH)D quartiles (mean 70.9nmol/L) compared
to those in the lowest quartile (mean 22.4nmol/L, P =
.01), after adjustment for age, sex, and month of blood
draw [60]. This observation, however, was subsequently
negated to nonsigniﬁcance (P = .05–.07) after further
adjustments for confounders such as BMI and leisure-
time exercise. A pooled, nested case-control analysis of the
Mini-Finland Health Study and the Finnish Mobile Clinic
Health Examination Survey revealed an 82% reduced risk
of T2DM incidence in men with the highest 25(OH)D
quartiles (mean 69.11nmol/L) versus those with the lowest
quartiles (mean 22.3nmol/L, P<. 001) after adjustment
for BMI, physical activity, smoking, and education [62].
A statistically signiﬁcant reduced risk was not shown in
women. Intermediate markers of T2DM risk, such as insulin
resistance, were not reported in the latter studies. The role
of serum 25(OH)D in predicting the risk for T2DM and
insulin resistance in non-Caucasian ethnic populations, such
as those with African, Asian, and Indian-descent is worth
investigating, as these populations are at high risk for T2DM
and low 25(OH)D concentrations.
5. InterventionStudies
Table 2(a) summarizes results of available vitamin D inter-
vention studies on insulin secretion. Gedik and Akalin [65]
ﬁrst reported impairment in insulin secretion in 4 relatively
healthy subjects presenting with vitamin D deﬁciency, and
their insulin secretion was normalized after 6 months of
vitamin D supplementation. Other studies have reported
signiﬁcant improvement in insulin secretion after variable
doses and lengths of vitamin D3 supplementation in subjects
with or at risk for T2DM [41, 66], as did a study using
alphacalcidiol as the intervention [67]. Antithetically, studies
that have used 1,25(OH)2D to supplement have not shown
signiﬁcantimprovementininsulinsecretion[42,68].Insofar
asthepancreaticβ-cellisendowedwiththeabilitytoproduce
1,25(OH)2D by an autocrine mechanism, supplementation
with vitamin D3 or D2 to produce a rise in circulating
25(OH)D may be superior as 25(OH)D serves as the nec-
essary substrate for extra-renal 1-α-hydroxylase [90, 91]. Of
note, there was a tendency toward a better insulin secretory
response in recently diagnosed (within 3years) T2DM sub-
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previous notion that vitamin D supplementation may not be
usefulonce β-cellsareexhausted. Studies using HOMA-β,an
indirect index of β-cell function derived from fasting values
of glucose and insulin, as the insulin secretory outcome, have
likewise not shown signiﬁcant changes in insulin secretion
[69, 70]. The majority of available studies, regardless of a
positive or negative outcome, are limited by their lack of
a randomized, placebo-controlled design [41, 65, 66, 68],
and/or nonreporting of serum 25(OH)D to ensure attain-
ment of suﬃcient vitamin D concentrations [42, 65, 67, 68].
With regards to insulin sensitivity, studies in subjects
with chronic renal disease have shown intravenous vitamin
D administration to improve insulin sensitivity [92, 93].
Human studies in relatively healthy populations without
renal disease have been inconsistent, particularly those using
indirect indices of insulin sensitivity (Table 2(b)). Studies
using fasting values of glucose and insulin (e.g., HOMA-
IR), which primarily reﬂect hepatic insulin sensitivity, have
generallynotshownsigniﬁcantimprovementsininsulinsen-
sitivity after vitamin D intervention [66, 69, 71, 72]. Posthoc
analyses, however, from a randomized placebo-controlled
trial revealed improved HOMA-IR after 3 years of 700IU
vitamin D3 plus 500mg calcium citrate daily supplemen-
tation in Caucasian subjects with impaired fasting glucose,
but not normal fasting glucose [73]. This study could not
discriminate the relative inﬂuences of vitamin D over cal-
cium. Vitamin D supplementation is more likely to inﬂuence
peripheral insulin sensitivity, as shown by Nagpal et al.
[70], whereby 3doses of 120000IU vitamin D3 fortnightly
versus placebo showed signiﬁcant improvements in a 3-
hour OGTT-derived insulin sensitivity index, but not indices
derived from fasting values, in Asian-Indian men. Additional
studies that have used OGTT-derived indices are limited by
relatively small sample sizes, lack of randomized placebo-
controlled design, and short-term supplementation [74, 75].
ThefewstudiesinvestigatingvitaminDeﬀectsondirectly
measured insulin sensitivity using the euglycemic clamp
technique or intravenous glucose tolerance testing (IVGTT)
have not shown improvements in insulin sensitivity with
supplementation [52, 76, 77]( T a b l e2(b)). The null eﬀects
in 2 studies [52, 76] may, at least in part, be explained
by the vitamin D suﬃciency of the subject populations. As
suggested by Jorde and Figenschau [69], supplementation of
vitamin D-suﬃcient populations may not incur additional
glucose regulating eﬀects. In addition, all studies used the
active form of vitamin D (1,25(OH)2D) or an analog of this
hormone to supplement, and the increase in 25(OH)D was
minimal in one study [76] and unable to be evaluated in the
others [52, 77]. It is plausible that results would have diﬀered
in vitamin D deﬁcient subjects supplemented with cholecal-
ciferol or ergocalciferol to produce a rise in serum 25(OH)D.
There is no universally accepted deﬁnition for the
optimal serum concentration of 25(OH) D, thus compli-
cating vitamin D supplementation trials. For prevention of
rickets or osteomalacia, a serum 25(OH)D concentration of
25mmol/L(10ng/mL)isconsideredsuﬃcient;yettoprevent
osteoporosis and maximize calcium absorption a concen-
tration of 75nmol/L (30ng/mL) is suggested [1]. Vitamin
D deﬁciency is deﬁned as serum 25(OH)D < 50nmol/L
(<20ng/mL) [94]. As summarized by Pepper et al. [94],
there is also no universally accepted standard regimen for the
correction of vitamin D deﬁciency. It is also unknown what
length of intervention or duration of follow-up once vitamin
D is replete is required to appreciate the eﬀects of vitamin
D on insulin sensitivity and secretion. Further confounding
conclusions are that the reported vitamin D intervention
studiesareheterogeneousintheirresearchdesignandlength,
form, and dosage of vitamin D supplementation. Many also
lack the demonstration of achieving a therapeutic level of
vitamin D. Additionally, the majority of intervention trials
have been performed in Caucasian subjects. There is a need
for more intervention studies in subjects of non-Caucasian
descent.
6. Vitamin DReceptor Polymorphisms
Polymorphisms in the VDR gene, namely, TaqI,B s m I,A p a I,
and FokI, have been identiﬁed and may inﬂuence insulin
secretion and sensitivity, although relatively few studies
have been conducted and, results have varied (Table 3).
Among a cohort of Bangladeshi Asians, the ApaIV D Rg e n e
polymorphism was associated with insulin secretion index
[79]; however reanalysis of this cohort revealed TaqIt ob e
theindependentpredictoroftheinsulinsecretionindex[80].
In contrast, the BsmI VDR gene polymorphism was asso-
ciated with postprandial C-peptide concentrations among
Caucasian Hungarians [78]. The ApaIa n dBsmIV D Rg e n e
polymorphismswerealsoshowntobeassociatedwithfasting
glucose and HOMA-IR, respectively, among a large cohort
of Caucasian Americans [83], and BsmI was associated with
fasting glucose in a large cohort of Germans [84]. The
linkage disequilibrium that exists between the TaqI,B s m I
and ApaI polymorphisms may partly explain the varying
results [80, 88]. The FokI VDR polymorphism was also
associated with indices of insulin resistance among Polish
men [81] and among Caucasian Americans [82], although
the studies contradicted each other regarding the speciﬁc
genotype associated with insulin resistance (FF versus ﬀ).
Despite the support for a VDR gene polymorphism
inﬂuencing insulin secretion and resistance, case-control
studies, in general, have not found statistical diﬀerences
in VDR gene polymorphism frequencies among subjects
with T2DM versus controls [86–89]. Ortlepp et al. [84]
did, however, report a higher prevalence of T2DM among
GermansubjectswiththeBBgenotypeoftheBsmIVDRgene
polymorphism compared to those with the bb genotype. The
association between VDR gene polymorphisms and insulin
secretion and sensitivity should be conﬁrmed using direct
methods, such as IVGTT or clamp studies. In addition, these
associationsshouldbeinvestigatedinAfricanAmericansand
other non-Caucasian ethnicities.
7. VitaminDand the Insulin-LikeGrowth
Factor (IGF) System
There is some evidence to suggest that vitamin D status
may interact with the IGF system to inﬂuence glucoseInternational Journal of Endocrinology 15
homeostasis [61, 64]. Analysis of the 1958 British Birth
Cohort revealed a lower risk for metabolic syndrome in
subjectswiththehighesttertilesofbothserum25(OH)Dand
IGF-1 concentrations, although there was no statistical inter-
action between 25(OH)D and IGF-1 in any of the individual
components of the metabolic syndrome and HbA1c [64].
In a prospective study, Forouhi et al. [61] found an inverse
relationship between baseline 25(OH)D and 10-year follow-
up fasting and 2-hour glucose only in subjects with baseline
IGF binding protein-1 (IGFBP-1) concentrations below the
median. An interaction between vitamin D and the IGF axis
to inﬂuence glucose homeostasis seems conceivable as each
has been shown to directly enhance the other [95, 96].
8. Summary and Conclusion
There is mechanistic support that vitamin D may inﬂuence
both insulin secretion and insulin sensitivity and subse-
quently T2DM incidence. In general, cross-sectional and
prospective studies support the role of vitamin D in the
prevention of T2DM. Despite the inherent limitations of
cross-sectional and prospective study designs, these types
of study designs are useful for preliminary research to
suggest which speciﬁc populations may respond to vitamin
D interventions. Future cross-sectional and prospective
studies should focus on non-Caucasian ethnicities with
a high risk of both T2DM and vitamin D deﬁciency.
Cross-sectional and prospective studies should account for
potential confounders of the vitamin D-T2DM relationship,
including age, ethnicity, obesity, physical activity, and diet, as
well as use direct measures of adiposity, insulin sensitivity,
and insulin secretion. Results of vitamin D intervention
studies are equivocal; yet many studies are ﬂawed by lack
of randomized, placebo-controlled design, use of indirect
measures of insulin secretion and sensitivity, small sample
size, and inability to show relevant increases in serum
25(OH)D.Thelackofprotocolforoptimaldosingofvitamin
D and lack of deﬁnition for optimal therapeutic concentra-
tions of serum 25(OH)D further inhibit the application of
vitamin D intervention trials. One could also postulate that
interactionswiththeIGFsystem,VDRgenepolymorphisms,
or other individual genotypes of subjects might becloud
the conﬂicting conclusions. It is plausible that vitamin D
has a role in improving insulin secretion and sensitivity,
but may not be eﬀective in insulinopenic situations, or that
beyond a certain concentration of vitamin D level, further
supplementation of vitamin D suﬃc i e n ts u b j e c t sm a yn o tb e
of value in improving glucose homeostasis.
Basedonareviewofliterature,atrue,directlinkbetween
vitamin D and risk for T2DM has not yet been conclusively
established, although several unknowns remain. It is not
known what the optimal concentration of vitamin D for
glucose homeostasis should be and what duration of follow-
up is necessary to appreciate the eﬀects of vitamin D on
insulin secretion and sensitivity. It is also unclear if a serum
25(OH)D threshold exists for which vitamin D does not
incur additional beneﬁts for glucose homeostasis, if vitamin
D inﬂuences are ethnic-speciﬁc, or if there are diﬀerent
optimal thresholds for diﬀerent ethnic groups. Large, well-
controlled, randomized studies are required to clarify these
important unknowns and deﬁne the relationship between
vitamin D status and glucose homeostasis.
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